Galmed Pharmaceuticals
GLMD
#10243
Rank
S$4.8 M
Marketcap
$2.13
Share price
-0.61%
Change (1 day)
-67.44%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2024 (TTM): -S$8.36 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$9.08 Million, an increase over its 2022 earnings that were of -S$23.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$8.36 Million-7.99%
2023 -S$9.08 Million-61.31%
2022 -S$23.47 Million-44.97%
2021 -S$42.64 Million12.85%
2020 -S$37.79 Million40.61%
2019 -S$26.88 Million109.19%
2018 -S$12.85 Million-20.47%
2017 -S$16.16 Million-27%
2016 -S$22.13 Million58.6%
2015 -S$13.95 Million16.7%
2014 -S$11.96 Million-47.94%
2013 -S$22.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.12 Billion 1,338.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$3.15 Billion 37,722.90%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-S$30.53 Million 267.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$6.38 Million-23.30%๐Ÿ‡บ๐Ÿ‡ธ USA